COMMUNIQUÉS West-GlobeNewswire
-
IN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid Leukemia
04/09/2024 - 22:01 -
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2024 - 22:00 -
Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.
04/09/2024 - 20:00 -
Ipsen - August 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital
04/09/2024 - 18:00 -
Ipsen - Août 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
04/09/2024 - 18:00 -
VALNEVA - Declaration of shares and voting rights: August 31, 2024
04/09/2024 - 18:00 -
VALNEVA - Déclaration d’actions et de droits de vote : 31 août 2024
04/09/2024 - 18:00 -
Americans Are Wandering in Wonderland, Writes President of the Association of American Physicians and Surgeons (AAPS)
04/09/2024 - 17:36 -
Politicized Medicine Hindered Use of Ivermectin for COVID, according to the Journal of American Physicians and Surgeons
04/09/2024 - 17:12 -
Greg Thompson Joins NewLeaf Board of Directors
04/09/2024 - 17:05 -
Wellinks Recognized as Quarterfinalist for the Digital Health Hub Foundation: Digital Health Awards
04/09/2024 - 17:00 -
Artificial Intelligence Systems (AI) Are Programmed to Lie, according to Journal of American Physicians and Surgeons
04/09/2024 - 16:48 -
Methods to Undo Damage from Bad-Faith Peer Review Discussed in Journal of American Physicians and Surgeons
04/09/2024 - 16:40 -
ARCPOINT PROVIDES CORPORATE UPDATE ON BENEFITS OF CRESSO TRANSACTION
03/09/2024 - 22:52 -
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
03/09/2024 - 22:50 -
Protect Pharmaceutical Corp. Announces that KARINCA Logistics Merger Will Not Proceed
03/09/2024 - 22:45 -
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/09/2024 - 22:40 -
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to October 3, 2024
03/09/2024 - 22:35 -
Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c)
03/09/2024 - 22:30
Pages